AKT regulates BRCA1 stability in response to hormone signaling

Abstract

BRCA1, with its binding partner BARD1, regulates the cellular response to DNA damage in multiple tissues, yet inherited mutations within BRCA1 result specifically in breast and ovarian cancers. This observation, along with several other lines of evidence, suggests a functional relationship may exist between hormone signaling and BRCA1 function. Our data demonstrates that AKT activation promotes the expression of BRCA1 in response to estrogen and IGF-1 receptor signaling. Further, we have identified a novel AKT phosphorylation site in BRCA1 at S694 which is responsive to activation of these signaling pathways. This rapid increase in BRCA1 protein levels appears to occur independently of new protein synthesis and treatment with the clinically utilized proteasome inhibitor bortezomib similarly leads to a rapid increase in BRCA1 protein levels. Together, these data suggest that AKT phosphorylation of BRCA1 increases total protein expression by preventing proteasomal degradation. AKT activation also appears to support nuclear localization of BRCA1, and co-expression of activated AKT with BRCA1 decreases radiation sensitivity, suggesting this interaction has functional consequences for BRCA1's role in DNA repair. We conclude that AKT regulates BRCA1 protein stability and function through direct phosphorylation of BRCA1. Further, the responsiveness of the AKT-BRCA1 regulatory pathway to hormone signaling may, in part, underlie the tissue specificity of BRCA1 mutant This is an un

Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer

“…By late S phase BRCA1 resumes being a predominantly nuclear protein (20–22). Activation of the protein kinase b (Akt) has been implicated in the nuclear/cytoplasmic shuttling of BRCA1 protein in breast cells (23–26). …”

IGF antagonizes the Wnt/β-Catenin pathway and promotes differentiation of extra-embryonic endoderm

“…As a result TNKS2-mediated ADP-ribosylation of Axin and subsequent ubiquitination is inhibited and Axin protein is stabilized (Guo et al, 2012). Furthermore, direct phosphorylation of Axin1 protein by the PI3K/Akt pathway might trigger its stabilization, as shown for other proteins (Byles et al, 2010;Nelson et al, 2010;Pellegrino et al, 2014). This hypothesis is supported by the fact that Axin1 gets also stabilized by phosphorylation through GSK3 in the β-Catenin degradation complex.…”

Power of PTEN/AKT: Molecular switch between tumor suppressors and oncogenes

“…While p53 is regulated indirectly or directly by PTEN, PTEN loss may affect BRCA1 cellular localization and thereby switch the BRCA1 from a tumor suppressor to an oncogenic resistant gene in radiation therapy. On the other hand, AKT has been found to phosphorylate BRCA1 to enhance its nuclear localization and stability, which results in the inhibition of radiation sensitivity (40). Thus, the PTEN loss/AKT activation pathway is most likely able to convert BRCA1 function.…”